Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th annual meeting of the European Association for the Study of Diabetes

Press/Media: Press / Media

PeriodSep 24 2019

Media coverage

1

Media coverage

  • TitleDetailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th annual meeting of the European Association for the Study of Diabetes
    Media name/outletM2Pharma.com
    CountryUnited States
    Date9/24/19
    PersonsRalph A Defronzo